Brief: Index Pharmaceuticals Says COO Pernilla Sandwall Has Decided To Leave Company To Become CEO Of WntResearch
Feb 13 (Reuters) - Index Pharmaceuticals Holding Ab
INDEX.ST :
* COO PERNILLA SANDWALL HAS DECIDED TO LEAVE COMPANY TO
BECOME CEO
OF WNTRESEARCH
* SANDWALL WILL CONTINUE IN HER CURRENT ROLE UNTIL END OF
APRIL
* PROCESS TO RECRUIT SANDWALL SUCCESSOR WILL BE INITIATED
IMMEDIATELY
Source text for Eikon: ID:nWkr6QdX2l
Further company coverage: INDEX.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen